9 Jan 2015 17:00
9 January 2015
Plethora Solutions Holdings PLC
("Plethora" or the "Company")
Plethora Solutions to attend the J.P. Morgan Annual Healthcare Conference 2015
Plethora Solutions Holdings PLC (AIM: PLE) announces that it will be attending the 33rd J.P. Morgan Annual Healthcare Conference in San Francisco (12-15 January, 2015).
The presentation Plethora's management will be discussing with shareholders/potential investors at the conference can be viewed on the Investor Relations section of the Company's website: http://www.plethorasolutions.co.uk/investors-presentations.php.
Ends
Plethora Solutions Jamie Gibson, CEO Mike Wyllie, CSO Mike Collis, CFO
| Tel : +44(0) 20 3077 5400 |
finnCap (Nomad & Broker) Geoff Nash/James Thompson Stephen Norcross | Tel : +44(0) 20 7220 0500 (Corporate Finance) (Corporate Broking) |
Citigate Dewe Rogerson David Dible Malcolm Robertson |
Tel: +44(0) 20 7282 2949 Tel: +44(0) 20 7282 2867 |
About Plethora
Plethora is focused on commercialising FORTACIN™ for the treatment of premature ejaculation with strategic marketing partners and obtaining NDA approval for FORTACIN™ with the FDA.
Plethora is headquartered in the UK and is listed on the London Stock Exchange (AIM: PLE LN). Further information is available at www.plethorasolutions.co.uk
Plethora Solutions Holdings Plc (PLE)